
Sign up to save your podcasts
Or


Dr John Strickler from Duke University in Durham, North Carolina, discusses the measurement of molecular residual disease and its current and potential role in colorectal cancer risk assessment, surveillance and treatment decision-making.
CME information and select publications here.
By Dr. Neil Love4.9
5656 ratings
Dr John Strickler from Duke University in Durham, North Carolina, discusses the measurement of molecular residual disease and its current and potential role in colorectal cancer risk assessment, surveillance and treatment decision-making.
CME information and select publications here.

139 Listeners

325 Listeners

498 Listeners

65 Listeners

30 Listeners

76 Listeners

14 Listeners

17 Listeners

12 Listeners

0 Listeners

120 Listeners

59 Listeners

3,360 Listeners

204 Listeners

43 Listeners

22 Listeners

369 Listeners

193 Listeners

42 Listeners

0 Listeners